RE: Epigenetic profiling and response to CD19 chimeric antigen receptor T-cell therapy in B-cell malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RE: Epigenetic profiling and response to CD19 chimeric antigen receptor T-cell therapy in B-cell malignancies

Published:2023-08-18 Issue:10 Volume:115 Page:1231-1233
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Lee Hwan Young¹²,Yang Soo-Bin¹,Park Mi Young³⁴,Baek Gyung Won³⁴,Kang Hyoung Jin³⁴⁵⁶^ORCID

Affiliation:

1. Department of Forensic Medicine, Seoul National University College of Medicine , Seoul, Korea

2. Institute of Forensic and Anthropological Science, Seoul National University College of Medicine , Seoul, Korea

3. Department of Pediatrics, Seoul National University College of Medicine , Seoul, Korea

4. Seoul National University Cancer Research Institute , Seoul, Korea

5. Seoul National University Children’s Hospital , Seoul, Korea

6. Wide River Institute of Immunology , Hongcheon-gun, Gangwon-do, Korea

Funder

Korea Health Technology R&D

Korea Health Industry Development Institute

Ministry of Health & Welfare

Republic of Korea

National Research Foundation of Korea

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://academic.oup.com/jnci/advance-article-pdf/doi/10.1093/jnci/djad165/51514121/djad165.pdf

Reference4 articles.

1. Epigenetic profiling and response to CD19 chimeric antigen receptor T-cell therapy in B-cell malignancies;Garcia-Prieto;J Natl Cancer Inst,2022

2. Clinical implications of T cell exhaustion for cancer immunotherapy;Chow;Nat Rev Clin Oncol,2022

3. CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome;Arcangeli;J Clin Invest,2022

4. Enhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling;Salas;Nat Commun,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to Kang et al.;JNCI: Journal of the National Cancer Institute;2023-08-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3